A novel drug response score more accurately predicts renoprotective drug effects than existing renal risk scores by Idzerda, Nienke M. A., Tye, Sok Cin, Zeeuw, Dick de, Heerspink, Hiddo J. L.

Get full text

Prediction of the effect of dapagliflozin on kidney and heart failure outcomes based on short-term changes in multiple risk markers by Idzerda, Nienke M A, Stefansson, Bergur V, Pena, Michelle J, Sjostrom, David C, Wheeler, David C, Heerspink, Hiddo J L

Get full text

Proteinuria and cholesterol reduction are independently associated with less renal function decline in statin-treated patients; a post hoc analysis of the PLANET trials by Idzerda, Nienke M A, Pena, Michelle J, Parving, Hans-Henrik, de Zeeuw, Dick, Heerspink, Hiddo J L

Get full text

An acute rise of plasma Na + concentration associates with syndecan-1 shedding during hemodialysis by Koch, Josephine, Idzerda, Nienke M. A., Ettema, Esmée M., Kuipers, Johanna, Dam, Wendy, van den Born, Jacob, Franssen, Casper F. M.

Get full text

Plasma syndecan-1 in hemodialysis patients associates with survival and lower markers of volume status by Koch, Josephine, Idzerda, Nienke M A, Dam, Wendy, Assa, Solmaz, Franssen, Casper F M, van den Born, Jacob

Get full text

Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL by Idzerda, Nienke M. A., Clegg, Lindsay E., Hernandez, Adrian F., Bakris, George, Penland, Robert C., Boulton, David W., Bethel, M. Angelyn, Holman, Rury R., Heerspink, Hiddo J. L.

Get full text

N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) predicts the cardio‐renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk by Idzerda, Nienke M. A., Persson, Frederik, Pena, Michelle J., Brenner, Barry M., Brunel, Patrick, Chaturvedi, Nish, McMurray, John J., Parving, Hans‐Henrik, de Zeeuw, Dick, Heerspink, Hiddo J. L.

Get full text